165 related articles for article (PubMed ID: 37236430)
1. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
Mercadante S; Cascio AL; Casuccio A
J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
[TBL] [Abstract][Full Text] [Related]
2. Rapid Titration With Intravenous Oxycodone for Severe Cancer Pain and Oral Conversion Ratio.
Mercadante S; Adile C; Ferrera P; Cascio AL; Casuccio A
J Pain Symptom Manage; 2022 Dec; 64(6):532-536. PubMed ID: 36115502
[TBL] [Abstract][Full Text] [Related]
3. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
4. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
[TBL] [Abstract][Full Text] [Related]
5. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two techniques (intermittent intravenous bolus morphine vs. morphine infusion) for analgesic titration in patients who had advanced cancer with severe pain: a prospective randomised study.
Kumar V; Sirohiya P; Garg R; Gupta N; Bharti SJ; Velpandian T; Mishra S; Bhatnagar S
BMJ Support Palliat Care; 2023 Sep; 13(3):338-344. PubMed ID: 32895226
[TBL] [Abstract][Full Text] [Related]
7. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
8. Conversion ratios for opioid switching: a pragmatic study.
Mercadante S; Adile C; Ferrera P; Grassi Y; Cascio AL; Casuccio A
Support Care Cancer; 2022 Dec; 31(1):91. PubMed ID: 36580152
[TBL] [Abstract][Full Text] [Related]
9. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral versus intravenous methadone on postoperative pain and opioid use after adult spinal deformity surgery: A retrospective, non-inferiority analysis.
Esfahani K; Tennant W; Tsang S; Naik BI; Dunn LK
PLoS One; 2023; 18(7):e0288988. PubMed ID: 37478144
[TBL] [Abstract][Full Text] [Related]
11. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
[TBL] [Abstract][Full Text] [Related]
12. Methadone as First-line Opioid for the Management of Cancer Pain.
Mercadante S; Adile C; Ferrera P; Pallotti MC; Ricci M; Bonanno G; Casuccio A
Oncologist; 2022 Apr; 27(4):323-327. PubMed ID: 35380722
[TBL] [Abstract][Full Text] [Related]
13. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
14. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
16. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
[TBL] [Abstract][Full Text] [Related]
17. Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit.
Mercadante S; Prestia G; Ranieri M; Giarratano A; Casuccio A
Support Care Cancer; 2013 Jul; 21(7):1853-9. PubMed ID: 23400316
[TBL] [Abstract][Full Text] [Related]
18. Opioid-induced hyperalgesia after rapid titration with intravenous morphine: Switching and re-titration to intravenous methadone.
Mercadante S; Ferrera P; Arcuri E; Casuccio A
Ann Palliat Med; 2012 Apr; 1(1):10-3. PubMed ID: 25841426
[TBL] [Abstract][Full Text] [Related]
19. Dose ratios between high dose oral morphine or equivalents and oral methadone.
Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
[TBL] [Abstract][Full Text] [Related]
20. Methadone titration in opioid-resistant cancer pain.
Scholes CF; Gonty N; Trotman IF
Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
